Document Detail


Pivotal Trial to Evaluate the Safety and Efficacy of the Orbital Atherectomy System in Treating De Novo, Severely Calcified Coronary Lesions (ORBIT II).
MedLine Citation:
PMID:  24852804     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
OBJECTIVES: The ORBIT II (Evaluate the Safety and Efficacy of OAS in Treating Severely Calcified Coronary Lesions) trial evaluated the safety and efficacy of the coronary Orbital Atherectomy System (OAS) to prepare de novo, severely calcified coronary lesions for stent placement.
BACKGROUND: Despite advances in interventional techniques, treatment of calcified coronary lesions remains a challenge. Stent placement in these lesions may result in stent underexpansion, malapposition, and procedural complications.
METHODS: ORBIT II is a prospective, multicenter, nonblinded clinical trial that enrolled 443 consecutive patients with severely calcified coronary lesions at 49 U.S. sites from May 25, 2010, to November 26, 2012. Investigators used the centrifugal action of the OAS diamond-coated crown to modify calcified lesions prior to stent placement.
RESULTS: The pre-procedure mean minimal lumen diameter of 0.5 mm increased to 2.9 mm after the procedure. The primary safety endpoint was 89.6% freedom from 30-day major adverse cardiac events compared with the performance goal of 83%. The primary efficacy endpoint (residual stenosis <50% post-stent without in-hospital major adverse cardiac events) was 88.9% compared with the performance goal of 82%. Stent delivery occurred successfully in 97.7% of cases with <50% stenosis in 98.6% of subjects. Low rates of in-hospital Q-wave myocardial infarction (0.7%), cardiac death (0.2%), and target vessel revascularization (0.7%) were reported.
CONCLUSIONS: The ORBIT II coronary OAS trial met both the primary safety and efficacy endpoints by significant margins. Preparation of severely calcified plaque with the OAS not only helped facilitate stent delivery, but improved both acute and 30-day clinical outcomes compared with the outcomes of historic control subjects in this difficult-to-treat patient population. (Evaluate the Safety and Efficacy of OAS in Treating Severely Calcified Coronary Lesions [ORBIT II]; NCT01092416).
Authors:
Jeffrey W Chambers; Robert L Feldman; Stevan I Himmelstein; Rohit Bhatheja; Augusto E Villa; Neil E Strickman; Richard A Shlofmitz; Daniel D Dulas; Dinesh Arab; Puneet K Khanna; Arthur C Lee; Magdi G H Ghali; Rakesh R Shah; Thomas P Davis; Christopher Y Kim; Zaheed Tai; Kirit C Patel; Joseph A Puma; Prakash Makam; Barry D Bertolet; Georges Y Nseir
Related Documents :
19438734 - Migraine following trans-septal access for catheter ablation of cardiac arrhythmias.
15942344 - Prospective study of arterial and central venous catheter colonization and of arterial-...
7486414 - Method of salvaging long-term dialysis catheters.
12743004 - Effects of continuous enhanced vagal tone on dual atrioventricular node and accessory p...
16324024 - Anesthetic management of the neonate with congenital complete heart block: a 16-year re...
6744564 - Surgery for tricuspid regurgitation late after mitral valve replacement.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  JACC. Cardiovascular interventions     Volume:  7     ISSN:  1876-7605     ISO Abbreviation:  JACC Cardiovasc Interv     Publication Date:  2014 May 
Date Detail:
Created Date:  2014-05-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101467004     Medline TA:  JACC Cardiovasc Interv     Country:  United States    
Other Details:
Languages:  eng     Pagination:  510-8     Citation Subset:  IM    
Copyright Information:
Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Everolimus-eluting xience v/promus versus zotarolimus-eluting resolute stents in patients with diabe...
Next Document:  Effects of Transcatheter Pulmonary Valve Replacement on the Hemodynamic and Ventricular Response to...